Search
for
Sort by
Research 721–750 of 1000+
- The Association Between Polycystic Ovary Syndrome and Its Dermatological Manifestations
- Role of the ACTH/MC2R System in the Hair Cycle in Mice
- Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Polycystic ovary syndrome and psychological distress: Urban–rural comparison among reproductive-aged women in Bangladesh
- Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation
- Green and Emerging Microextraction Strategies for Bioanalytical Determination of Hormones: Trends, Challenges, and Applications
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia
- Is Withania somnifera (Ashwagandha) a safe and effective treatment for reducing perimenopausal symptoms?
- Cannabidiol in Skin Health: A Comprehensive Review of Topical Applications in Dermatology and Cosmetic Science
- Clinicopathological Features and Pathogenesis of Thymoma Complicated with Alopecia Areata: A Multicenter, Matched Case Analysis
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Suicidality Risks Associated with Finasteride, a 5-Alpha Reductase Inhibitor: An Evaluation of Real-World Data from the FDA Adverse Event Reports
- Gray Hair: From Preventive to Treatment
- Pediatric adrenocortical carcinoma complicated by uric acid nephrolithiasis: a unique case report
- Inflammatory Signatures and Biological Markers in Platelet-Rich Plasma Therapy for Hair Regrowth: A Comprehensive Narrative Analysis
- Male androgenetic alopecia
- POLYCYSTIC OVARY SYNDROME (PCOS): DIAGNOSIS, PATHOPHYSIOLOGY AND CONTEMPORARY THERAPEUTIC APPROACHES
- The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs
- Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Physical Treatments and Therapies for Androgenetic Alopecia
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- Aesthetic Rehabilitation Medicine: Enhancing Wellbeing beyond Functional Recovery